Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18367480rdf:typepubmed:Citationlld:pubmed
pubmed-article:18367480lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18367480lifeskim:mentionsumls-concept:C1171350lld:lifeskim
pubmed-article:18367480lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:18367480lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:18367480pubmed:issue5lld:pubmed
pubmed-article:18367480pubmed:dateCreated2008-5-2lld:pubmed
pubmed-article:18367480pubmed:abstractTextResistance to imatinib is an important clinical issue in the treatment of Philadelphia chromosome-positive leukemias which is being tackled by the development of new, more potent drugs, such as the dual Src/Abl tyrosine kinase inhibitors dasatinib and bosutinib and the imatinib analog nilotinib. In the current study we describe the design, synthesis and biological properties of an imatinib analog with a chlorine-substituted benzamide, namely compound 584 (cmp-584).lld:pubmed
pubmed-article:18367480pubmed:languageenglld:pubmed
pubmed-article:18367480pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:citationSubsetIMlld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18367480pubmed:statusMEDLINElld:pubmed
pubmed-article:18367480pubmed:monthMaylld:pubmed
pubmed-article:18367480pubmed:issn1592-8721lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:ClerisLoredan...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:MarchesiEdoar...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:Gambacorti-Pa...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:FormelliFranc...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:Donella-Deana...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:ZambonAlfonso...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:ScapozzaLeona...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:LucchiniVitto...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:GunbyRosalind...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:RedaelliSaraSlld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:MorettiLorisLlld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:SalaElisaElld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:MologniLucaLlld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:PuttiniMiriam...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:DrueckesPeter...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:KubbutatMicha...lld:pubmed
pubmed-article:18367480pubmed:authorpubmed-author:BrussoloStefa...lld:pubmed
pubmed-article:18367480pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18367480pubmed:volume93lld:pubmed
pubmed-article:18367480pubmed:ownerNLMlld:pubmed
pubmed-article:18367480pubmed:authorsCompleteYlld:pubmed
pubmed-article:18367480pubmed:pagination653-61lld:pubmed
pubmed-article:18367480pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:meshHeadingpubmed-meshheading:18367480...lld:pubmed
pubmed-article:18367480pubmed:year2008lld:pubmed
pubmed-article:18367480pubmed:articleTitleCharacterization of compound 584, an Abl kinase inhibitor with lasting effects.lld:pubmed
pubmed-article:18367480pubmed:affiliationSchool of Pharmaceutical Sciences, University of Geneva, Quai Ernest-Ansermet 30, 1211 Genève 4, Switzerland.lld:pubmed
pubmed-article:18367480pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18367480pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18367480lld:pdb
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18367480lld:pubmed